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Abstract
Introduction: Organ-specific autoimmune diseases are believed to result from
immune responses generated against self-antigens specific to each organ. However,
when such responses target antigens expressed promiscuously in multiple tissues,
then the immune-mediated damage may be wide spread.
Methods: In this report, we describe a mitochondrial protein, branched chain
a-ketoacid dehydrogenase kinase (BCKDk) that can act as a target autoantigen in
the development of autoimmune inflammatory reactions in both heart and liver.
Results: We demonstrate that BCKDk protein contains at least nine immunodo-
minant epitopes, three of which, BCKDk 71–90, BCKDk 111–130 and BCKDk
141–160, were found to induce varying degrees of myocarditis in immunized mice.
One of these, BCKDk 111–130, could also induce hepatitis without affecting lungs,
kidneys, skeletal muscles, and brain. In immunogenicity testing, all three peptides
induced antigen-specific T cell responses, as verified by proliferation assay and/or
major histocompatibility complex class II/IAk dextramer staining. Finally, the
disease-inducing abilities of BCKDk peptides were correlated with the production
of interferon-g, and the activated T cells could transfer disease to naive recipients.
Conclusions: The disease induced by BCKDk peptides could serve as a useful
model to study the autoimmune events of inflammatory heart and liver diseases.
Introduction
Various infectious and non-infectious origins have been
implicated in the causation of myocarditis. Many affected
individuals recover spontaneously from myocarditis but, a
proportion of patients can develop chronic inflammation
leading to dilated cardiomyopathy (DCM) [1, 2]. Mecha-
nistically, autoimmune responses against cardiac antigens
are believed to mediate the development of DCM, as sera
from DCM patients have been shown to contain
autoantibodies for cardiac antigens, such as cardiac myosin,
and cardiac troponin-I (cTnI) [3–7]. Recently, we demon-
strated that the mitochondrial inner membrane protein,
adenine nucleotide translocator1 (ANT1) can be a target
autoantigen in the pathogenesis of DCM by identifying
ANT1 21–40 as the disease-inducing epitope in A/J mice [2].
In this report, we describe the potential relevance of the
mitochondrial matrix branched chain a-ketoacid dehydro-
genase (BCKD) complex proteins to myocarditis and
hepatitis.
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The BCKD complex includes three catalytic subunits (E1a
and E1b, E2, and E3) and two regulatory proteins, BCKD
kinase (BCKDk) and BCKD phosphatase, which bind
noncovalently to the core protein E2 subunit [8–11]. These
proteins can become targets for immune attack as
demonstrated by the detection of BCKD-reactive immune
complexes in DCM patients and such a reactivity appears to
be seen mostly in the E2 subunit [3, 12, 13]. Whether other
subunits of BCKD complex proteins can act as immune
targets in the mediation of autoimmune myocarditis is
unexplored. In our studies, we focused on BCKDk, the
critical negative regulator of E1a subunit to determine its
ability to induce myocarditis as its expression was found to
be more in heart than other organs [14–17]. Additionally,
existence of a single isomeric form of BCKDk enabled us to
generate overlapping peptide library to identify the
immunodominant epitopes unique to this protein. We
demonstrate that BCKDk contains at least nine epitopes,
three of which induce myocarditis in A/J mice by generating
interferon-g (IFN-g) producing autoreactive T cells. One of
these peptides also induces inflammation in the liver but
other organs, lungs, kidneys, skeletal muscles, and brain
remained unaffected.
Results
BCKDk contains multiple epitopes that can induce
myocarditis
The BCKDk overlapping peptide library that we had
generated consisted of 37 peptides (Supporting informa-
tion Table S1). We used acetylated peptides as they are
expected to prevent from intracellular degradation leading
to better binding with major histocompatibility complex
(MHC) molecules and better disease induction [2, 18, 19].
For initial screening, eight pools were prepared to contain
four to five peptides each, and the peptide/complete
Freund’s adjuvant (CFA) emulsions were administered to
groups of mice. After three weeks, T cell responses were
examined using bovine ribonuclease (RNase) 43–56 as a
control. We noted that one or more peptides in each group
induced significant dose-dependent T cell responses (1.2
to threefold), leading us to identify a total of 23 peptides as
potential immunodominant epitopes of BCKDk (Support-
ing information Table S2). The responses were specific to
BCKDk peptides as the antigen-sensitized cells did not
respond to irrelevant control (RNase 43–56) peptide. Since
our intent was to identify the disease-inducing epitopes, we
examined hearts for inflammatory changes by hematoxylin
and eosin (H & E) staining. The data revealed that hearts
obtained from groups II, III, and VIII showed mild
myocarditis, but heart sections derived from other groups
remained unaffected (data not shown).
To test their ability to induce myocarditis individually, we
selected a total of nine peptides, three from each of groups II
(BCKDk 61–80, BCKDk 71–90 and BCKDk 91–110), III
(BCKDk 111–130, BCKDk 121–140, and BCKDk 141–160)
and VIII (BCKDk 331–350, BCKDk 341–360, and BCKDk
351–370) (Supporting information Table S2). Three
peptides—BCKDk 111–130, BCKDk 71–90 and BCKDk
141–160—were found to inducemyocarditis in a descending
order (7/10, 5/10, and 2/10), and the number of inflamma-
tory foci in the respective groups were 5.29 2.67,
2.20 0.97, and 7.50 6.50 (Table 1). The control groups
(naive, CFA/pertussis toxin [PT] and RNase 43–56) lacked
inflammatory changes (Table 1). Both endocardium and
myocardium were found to be affected with a tendency for
lesions to be seen more in the BCKDk 111–130 group than
the other two peptides (BCKDk 71–90 and BCKDk 141–160)
(Fig. 1A). Immunohistochemistry (IHC) on heart sections of
BCKDk 111-130-immunized group, also stained positive for
CD3þ T cells and CD11bþ macrophages, the two common
leukocyte subsets expected in T cell-mediated inflammatory
reaction (Fig. 1B). The staining with isotype controls was
negative, and none of the sections were stained positive for
granulocytes as determined by staining with Ly6G antibody
(data not shown). Similarly, the control groups (naive, CFA/
PT and RNase 43–56) also lacked CD3þ and CD11bþ cells
(Fig. 1B). Thus, we identified BCKDk 111–130 as the primary
myocarditogenic epitope in A/J mice.
Echocardiographic analysis reveals cardiac
abnormalities in animals immunized with- BCKDk
111-130
Echocardiograms of animals immunized with BCKDk
111–130 revealed that the interventricular septal thickness
at end-diastole was increased compared to naive mice
(0.93 0.03mm vs. 0.70 0.06mm; p< 0.05), whereas the
Table 1. Histological evaluation of hearts obtained from mice
immunized with BCKDk peptides.
Groups Incidence (%) Inflammatory foci (mean SEM)
Naive 0/5 (0) 0
CFA/PT 0/5 (0) 0
RNase 43–56 0/5 (0) 0
BCKDk 61–80 0/5 (0) 0
BCKDk 71–90 5/10 (50) 2.20 0.97
BCKDk 91k110 0/5 (0) 0
BCKDk 111k130 7/10 (70) 5.29 2.67
BCKDk 121–140 0/5 (0) 0
BCKDk 141–160 2/10 (20) 7.50 6.50
BCKDk 331–350 0/5 (0) 0
BCKDk 341–360 0/5 (0) 0

p< 0.05 vs. naive, CFA/PT and RNase 43–56 group.
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Figure 1. Induction of myocarditis by BCKDk peptides in A/J mice. At termination on day 21 postimmunizations, hearts were collected for histological
evaluation. (A) H & E staining. Inflammatory foci are shownwith arrows in sections representing each group. Controls (naive, CFA/PT and RNase 43–56):
normal cardiac tissuewith intact myocytes; BCKDk 71–90:moderate inflammatory foci in the endocardium; BCKDk 111–130: multiple inflammatory foci
in the endocardium (left panel) and myocardium (right panel); and BCKDk 141–160: multiple foci in the endocardium. (Controls: n¼ 5 mice; BCKDk
71–90, BCKDk 111–130, and BCKDk 141–160: n¼ 5 mice/group from two independent experiments). (B) IHC. Heart sections obtained from controls
(naive, CFA/PT and RNase 43–56) and BCKDk 111–130 groupswere stainedwith antibodies for T cells (anti-CD3) andmacrophages (anti-CD11b) or their
isotype controls to detect cells positive for eachmarker shown (arrows). NoCD3þ andCD11bþ cells were detected in control groups butwere detected in
the sections derived from BCKDk 111-130-immunized animals (arrows). (Controls: n¼ 5mice each; BCKDk 111–130: n¼ 4mice). Original magnification
400 (scale bar: 20mm).
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left ventricular (LV) internal diameter at diastole remained
unaltered (Supporting information Table S3). Consistent
with this finding, heart weight and heart weight-to-body
weight ratios also were increased in animals immunized with
BCKDk 111–130 (Supporting information Fig. S1).
Functionally, although end diastolic and end systolic
volumes were reduced in the BCKDk 111-130-immunized
group, differences were not significant. The data suggest
BCKDk 111–130 could induce structural changes in the
hearts of myocarditic mice.
BCKDk 111–130 can induce autoimmune hepatitis
in immunized mice
Since BCKDk is also expressed in non-cardiac tissues such as
liver, lungs, kidneys, skeletal muscles, and brain, we
determined whether BCKDk peptides could induce inflam-
mation in multiple organs. Livers obtained from naive mice
showed the presence of scattered inflammatory cell foci
(1.80 0.58), and, as expected, their numbers were
significantly increased in those derived from the CFA/PT
group (21.89 2.75;p< 0.005) as we and others have
previously described [2, 20]. By using the CFA/PT group
as a baseline, we compared the inflammatory cell foci
detected in animals immunized with BCKDk peptides,
leading us to note that the livers from only the BCKDk
111-130-immunized group showed a significant increase in
the number of foci with leukocytes scattered all through the
parenchyma (69.59 8.98; p< 0.005), as compared to naive
or CFA/PT groups (Table 2). Such an increase was not noted
in animals immunized with a control peptide, RNase 43–56
(11.20 1.83) suggesting that the inflammatory changes
noted in BCKDk 111-130-immunized animals were specific
to antigen (Table 2). Histologically, foci were larger in
animals immunized with BCKDk 111–130 than in the
control groups (naive, CFA/PT, and RNase 43–56) and the
lesions comprising of lymphocytes and a few plasma cells
and neutrophils were noted in the periportal (centroacinar)
and midzonal areas (Fig. 2A). While similar trends were
observed in three groups— BCKDk 121–140, BCKDk
141–160, and BCKDk 331-350—(Table 2) the numbers of
liver foci were reduced in two other groups (BCKDk 61–80:
10.54 1.64 and BCKDk 341–360: 13.24 1.50). However,
no such variations were noted in the remaining groups
(BCKDk 71–90, BCKDk 91–110, and BCKDk 351–370).
Further, evaluation of other tissues such as lung, kidney,
skeletal muscle and brain, derived from animals immunized
with BCKDk 71–90, BCKDk 111–130 and BCKDk 141–160
did not reveal any leukocyte infiltrates (data not shown).
Since inflammatory foci in livers were increased selectively in
animals immunized with BCKDk 111–130, we enumerated
the numbers of CD3þ T cells, CD11bþ macrophages and
Ly6Gþ neutrophils by IHC. These analyses revealed T cell
numbers to be significantly higher in liver sections from
BCKDk 111-130-immunized animals (23.79 4.57) than
both CFA/PT (5.35 0.22), RNase 43–56 (5.81 0.24) and
naive groups (4.15 0.37) (Fig. 2B, top right panel).
Although, similar trends were noted with CD11bþ and
Ly6Gþ cells, the differences were not significant between
BCKDk 111-130-immunized animals and control groups
(CFA/PT and RNase 43–56) (CD11bþ: Fig. 2B, middle right
panel and Ly6Gþ cells: Fig. 2B, bottom right panel). Taken
together, the data suggest that BCKDk 111–130 has a
potential to induce autoimmune hepatitis in the immunized
animals.
Both pathogenic and nonpathogenic epitopes of
BCKDk can induce T cell responses in vitro
We performed T cell proliferation assay using a panel of nine
peptides. We first verified that all the three myocarditogenic
epitopes namely, BCKDk 71–90, BCKDk 111–130, and
BCKDk 141–160 induce specific T cell responses since the
corresponding antigen-sensitized cells did not respond to
control (RNase 43–56) peptide (Fig. 3). The dose-dependent
differences (up to threefold) were comparable between all
the three peptides, and the responses were significant relative
to control suggesting that their disease-inducing abilities
may involve the mediation of autoreactive T cells. Next, in a
similar analysis for six other peptides that failed to induce
myocarditis or hepatitis, we noted that all of them induced
significant proliferative responses when compared to RNase
43–56 (Supporting information Fig. S2). The finding that
multiple BCKDk epitopes could generate T cell responses
regardless of their ability to induce disease implies that
additional factors may be critical for epitopes to induce
pathology. Finally, to determine whether unimmunized
animals carry BCKDk-reactive T cells in their naive
Table 2. Histological evaluation of livers obtained frommice immunized
with BCKDk peptides.
Groups Incidence (%) Inflammatory foci (mean SEM)
Naive 5/5 (100) 1.80 0.58
CFA/PT 5/5 (100) 21.89 2.75
RNase 43–56 5/5 (100) 11.20 1.83
BCKDk 61–80 5/5 (100) 10.54 1.64
BCKDk 71–90 10/10 (100) 19.99 3.44
BCKDk 91–110 5/5 (100) 20.23 5.96
BCKDk 111–130 10/10 (100) 69.59 8.98
BCKDk 121–140 5/5 (100) 32.05 10.88
BCKDk 141–160 10/10 (100) 37.62 7.17
BCKDk 331–350 5/5 (100) 49.45 21.74
BCKDk 341–360 5/5 (100) 13.24 1.50
BCKDk 351–370 5/5 (100) 25.94 5.43
p< 0.005 vs. naive and/or CFA/PT group.
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Figure 2. Histological evaluation of livers obtained from mice immunized with BCKDk 111–130. Livers harvested from naive or day 21 postimmunized
animals were examined for inflammatory changes. (A) H & E staining. Liver sections obtained from naive animals had a small aggregate of lymphocytes,
as opposed to multiple scattered aggregates of mononuclear cells in animals immunized with CFA/PT and RNase 43–56, and similar changes, but with
more pronounced lesions/large aggregates of MNCs in the parenchyma, and also in the periportal (centroacinar) region, in animals immunized with
BCKDk 111–130 (circles, 10magnifications, scale bars: 80mm; horizontal arrows, 40magnifications, scale bars: 20mm). (Controls: n¼ 5 mice each;
BCKDk 111–130: n¼ 5 mice/group from two independent experiments). (B) IHC. Liver sections revealed isolated/scattered CD3þ cells in naive, CFA/PT
and RNase 43–56 groups that were elevated in animals immunized with BCKDk 111–130 (top panel: arrows and bar graph). Similar patterns with
CD11bþ and Ly6Gþ cells were noted between treatment groups (middle and bottom panels: arrows and bar graphs). Mean SEM values are shown in
bar graphs (CD3: n¼ 3 mice/group; CD11b: n¼ 4 mice/group and Ly6Gþ: n¼ 4 mice/group). Original magnification 400 (scale bar: 20mm). The p
values were determined using Student's t-test (p 0.05 and p 0.001).
B. Krishnan et al. Autoimmunity induced by branched chain a-ketoacid dehydrogenase kinase
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repertoires, we analyzed T cell responses using lymphocytes
obtained from naive A/J mice. Supporting information
Figure S3 did not reveal detectable repertoires of T cells that
react with any of the three peptides tested (BCKDk 71–90,
BCKDk 111–130, and BCKDk 141–160), suggesting that the
occurrence of myocarditis and/or hepatitis induced by
BCKDk peptides does not involve the expansion of the
preexisting peripheral repertoires of naive mice.
BCKDk epitopes can bind MHC class II allele, IA
k in
A/J mice
Using the soluble empty IAk molecules [21], we determined
the 50% inhibitory concentration (IC50) values for the three
test peptides that induced myocarditis and/or hepatitis. As
shown in Figure 4, BCKDk 71–90 was found to be a strong
binder of IAk molecules followed by BCKDk 111–130, and
BCKDk 141–160. Their respective IC50 values were
3.96 0.55mM, 66.42 4.09mM, and 104.00 6.75mM.
However, it is to be noted that A/J mice also express IEk as
another MHC class II allele, and there exists the possibility
that BCKDk 141–160 can bind the IE
k molecule, which we
have not investigated in this study.
The creation of IAk dextramers permits evaluation
of antigen-specificity of BCKDk-reactive T cells
To validate dextramers, we used lymph node cell (LNC)
cultures derived from BCKDk 111-130-immunized animals
as described previously [22]. Cells harvested from antigen-
stimulated cultures were harvested on day 9 poststimulation
with BCKDk 111–130, and the cells were stainedwith BCKDk
111–130 and control (RNase 43–56) dextramers. The flow
cytometric plots depicted in Figure 5A indicate that the CD4
T cells were stained with BCKDk 111–130 dextramers,
whereas the intensity of staining obtained with the control
dextramers was negligible (2.21% vs. 0.17%). Thus, we
demonstrated that T cell response induced with BCKDk
111–130 was antigen-specific. We next asked whether
antigen-specific T cells can infiltrate into the target organs.
Since, liver being a large organ, we were able to harvest
mononuclear cells (MNCs) from immunized animals that
permitted us to perform dextramer staining by flow
cytometry. MNCs were stimulated with BCKDk 111–130
and on day 8 postimulation, cells were subjected for
dextramer staining. The analysis revealed detection of
BCKDk 111–130 CD4
þdextramerþ T cells, but not control
dextramers (7.05% vs. 0.28%) (Fig. 5B) suggesting infiltra-
tion of antigen-specific T cells into the livers. Since animals
were perfused prior to harvesting MNCs from livers, it is
unlikely that BCKDk 111–130-reactive T cells might have
represented the peripheral blood compartment. Nonethe-
less, while flow cytometric analysis permits enumeration of
total number of antigen-specific T cells, determination of
their localization requires establishment of in situ staining
technique and we have not investigated this possibility.
Cytokine responses induced by BCKDk 111–130
were predominantly of T helper (Th) 1 phenotype
Culture supernatants from LNC cultures stimulated with or
without BCKDk 111–130 or irrelevant control (RNase
43–56) were subjected for cytokine analysis. The data
revealed that all groups showed the detection of all cytokines
tested except interleukin (IL)-4 (Fig. 6), but their patterns
varied. First, BCKDk 111-130-induced cytokine responses
included all three phenotypes—Th1 (IFN-g), Th2 (IL-10),
and Th17 (IL-17A)—including two other prototypical
inflammatory cytokines (IL-6 and tumor necrosis factor
(TNF)-a). Their levels were significantly higher than the
control groups. Second, production of IL-17A in RNase
43–56-stimulated cultures also tended to be greater than the
medium controls, implying that IL-17A production could
have been triggered non-antigen-specifically. Third, IL-2
Figure 3. T cell responses induced by myocarditogenic BCKDk peptides. LNCs prepared from immunized animals were stimulated with the immunizing
peptides or RNase 43–56 (control) for 2 days, cells were pulsedwith tritiated-thymidine for 16 h, and proliferative responsesweremeasured as counts per
minute (cpm). Mean SEM values obtained from three individual experiments, each representing two to three mice, are shown. The p values were
determined using Student's t-test (p< 0.05 and p< 0.001 between indicated doses).
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production was significantly lower in cultures stimulated
with BCKDk 111–130, but not in RNase 43-56-stimulated
cultures, indicating that the antigen-responsive T cells
consume IL-2 as it is secreted. Fourth, since production of
IFN-g was highest compared to other cytokines, we
determined the ratios between IFN-g (Th1) to IL-17A
(Th17), IL-10 (Th2), IL-6, and TNF-a to be 4, 201, 41, and
14-fold, respectively. Similar patterns also were observed for
one other myocarditogenic epitope, BCKDk 71–90, for
which supernatants of cultures obtained from animals
immunized for disease induction were evaluated for
cytokine analysis (Supporting information Fig. S4A). Under
similar conditions, however, inflammatory cytokines
produced by a weak myocarditogenic epitope (BCKDk
141-160; supporting information Fig. S4B) did not differ
significantly, indicating correlation between production of
inflammatory cytokines and disease severity. We conclude
that eventhough production of IL-10, an anti-inflammatory
cytokine, is increased in BCKDk 111-130-stimulated
cultures, such production was significantly lower
(40.79 6.51 pg/ml) than the sum production of all other
inflammatory cytokines (IFN-g, 8195.11 416.56 pg/ml;
IL-17A, 2036.30 290.86 pg/ml; IL-6, 200.22
28.15 pg/ml; and TNF-a, 582.81 116.72 pg/ml), negating
the anti-inflammatory effects of IL-10, leading to the
induction of inflammation in the target organs.
BCKDk 111-130-sensitized T cells can transfer
disease to naive animals
To evaluate the disease-inducing abilities of autoreactive T
cells, we used an adoptive transfer protocol to induce disease
in naive mice [2, 23, 24]. Heart sections obtained from
recipients of BCKDk 111-130-reactive T cells showed
multiple inflammatory foci in the myocardium
(6.70 2.40) and rarely necrosis, both of which were absent
in the control groups (naive and lipopolysaccharide [LPS]
primed; Fig. 7, top panel). In a similar analysis, other tissues,
except liver, remained unaffected (data not shown); the
number of inflammatory foci in livers from recipients of
BCKDk 111-130-senstized T cells was estimated to be higher
and larger (7.77 1.31) than those in naive (1.80 1.00) or
LPS/PT groups (0.25 0.25), and the lesions were localized
mostly to periportal (centroacinar) areas (Fig. 7, bottom
panel). These data complement the observations made in the
active immunization protocol as described above.
Discussion
In this report, we demonstrate that BCKDk, a mitochon-
drial protein, contains multiple epitopes that induce
varying degrees of inflammatory reactions in heart and/
or liver in A/J mice. We were able to identify three peptides
that are capable of inducing myocarditis—BCKDk 71–90,
BCKDk 111–130 and BCKDk 141–160—and BCKDk
111–130 being the efficient. All three peptides induced
similar inflammatory phenotypes without associated
necrosis. BCKDk 111-130-induced inflammatory lesion
contained both T cells and macrophages, suggesting that
the disease pathogenesis involves the mediation of classic
delayed hypersensitivity reaction as expected in T cell-
mediated autoimmune diseases [25]. Since most immu-
nized animals showed mild multifocal lesions, the
inflammatory damage induced by BCKDk peptides might
not be severe enough to cause necrotic changes as seen
Figure 4. Evaluation of binding affinities of BCKDk peptides to MHC
class II/IAk molecules. The reaction mixtures containing soluble, IAk
monomers, competitor peptides (BCKDk 71–90, BCKDk 111–130, BCKDk
141–160: 0.00001–200mM), and biotinylated hen egg lysozyme 46–61
(reference peptide; 1mM) were prepared individually, after the incuba-
tion the reaction mixture were transferred to fluorescence plates
precoated with IAk antibody in duplicates. After a series of washes,
europium-labeled streptavidin was added to DELFIA buffer followed by
DELFIA enhancer, and the fluorescence intensities were measured at
excitation/emission wavelengths of 340/615 nm to obtain the IC50 values
(n¼ 3).
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with other experimental autoimmune myocarditis (EAM)
models like cardiac myosin [19, 21] and cTnI [7, 26, 27].
Nonetheless, this degree of myocardial inflammation
caused regional increases in LV wall thickness as detected
by echocardiography, but other functional changes such as
end-diastolic volume and end-systolic volume were not
significantly altered, most likely reflecting the lack of
necrosis in these hearts. Taken together, our data suggest
that BCKDk, in spite of being a mitochondrial protein, can
become a target for immune attack resulting in autoim-
mune reactions in the heart. We also noted an autoim-
mune response in the liver, as inflammatory foci were
significantly elevated in livers from only BCKDk 111–130-
immunized group as compared to control groups (naive,
CFA/PT, and RNase 43–56). The lesions were also noted in
the periportal (centroacinar) areas as noted in the mouse
model of autoimmune hepatitis [28]. It should be noted,
however, that animals receiving CFA/PT can show
elevations in the inflammatory foci in the liver resulting
from non-specific effects of the adjuvant, as we and others
have reported previously [2, 20]. Nonetheless, the finding
that the number of liver foci were increased only in animals
immunized with BCKDk 111–130 but not the other eight
peptides and also an irrelevant antigen (RNase 43–56)
(Table 2) suggests that BCKDk 111–130 also can be an
autoantigen in the mediation of autoimmune hepatitis.
However, none of the three peptides tested (BCKDk 71–90,
BCKDk 111–130, and BCKDk 141–160) were found to
induce inflammation in lungs, kidneys, skeletal muscles,
and brain (data not shown). Thus, we have identified
BCKDk 111–130 as a major epitope that can induce
autoimmune inflammatory reactions in both heart and
liver in A/J mice.
We next investigated whether the disease induced with
BCKDk peptides can be correlated with T cell responses. As
expected, the three peptides, BCKDk 71–90, BCKDk
111–130, and BCKDk 141–160 that induced myocarditis
were also strong activators of T cells. In corollary, those
peptides (BCKDk 331–350 or BCKDk 341–360) that were
poor T cell activators were not able to induce disease.
Figure 5. Antigen-specificity of T cell responses induced by BCKDk
111–130. (A) LNCs. Viable cells harvested from BCKDk 111-130-reactive
LNC cultures on day 9 poststimulationwere stainedwith the indicated IAk
dextramers, anti-CD4 and 7-aminoactinomycin D. After acquiring the
cells by flow cytometry, dextramerþ cells were analyzed in the live
(7-aminoactinomycin D), CD4 subset. (B) MNCs from liver. Livers from
immunized animals were processed to obtain MNCs as described in the
methods section. After stimulating the cells with BCKDk 111–130 and
resting in IL-2 medium, cells were subjected for dextramer staining on
day 8 and the dextramerþ cells were determined as above. RNase 43–56
dextramers (control). Representative flow cytometric plots from three
individual experiments each involving two to three mice are shown.
Figure 6. Cytokine responses induced by BCKDk 111–130. LNCs obtained from immunized mice were stimulated with or without BCKDk 111–130 or
RNase 43–56 (control). Supernatants collected on day 3 poststimulation were examined by cytometric bead array analysis. Mean SEM values obtained
from three individual experiments are shown. The p values were determined using Student's t-test (p< 0.05 and p< 0.005). ND; not detectable.
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However, not all the peptides that activated T cells could
induce disease for example, BCKDk 121–140 (Supporting
information Fig. S2; Table 1) supporting the notion that
appearance of autoreactive T cells does not necessarily lead
to pathogenic outcomes. Further, by determining the
cytokine responses, we noted that BCKDk 111–130-
senstitized cultures showed the predominant levels of
IFN-g, followed by IL-17A and other inflammatory
cytokines (TNF-a and IL-6) (Fig. 6). While these results
agree with the expected cytokine pattern as seen in other
EAMmodels such as cardiac myosin, cTnI, and ANT1 [2, 26,
27, 29, 30], we also found elevated levels of the anti-
inflammatory cytokine IL-10. However, IL-10 at a 200-
fold decreased level than that of IFN-g alone suggests that
eventhough both pro- and anti-inflammatory cytokine
responses occur with BCKDk, the balance is shifted in favor
of the pro-inflammatory state. Additionally, in an adoptive
transfer protocol, we demonstrated that BCKDk 111–130-
sensitized T cells can transfer disease to naive mice as the
recipients showed both myocardial and liver lesions. We
have consistently seen that hearts from control groups (naive
and LPS/PT) do not show inflammatory foci [21, 24]. As to
livers, however, scattered inflammatory foci were present as
expected in both control groups, but their detection was
significantly enhanced in the recipients of BCKDk 111–130-
reactive T cells suggesting a role for antigen-specific T cells in
the development of hepatitis. Detection of BCKDk 111-130-
dextramerþ T cells in livers from immunized animals also
supports this possibility. However, it is to be noted that local
inflammatory environment in the liver can promote
recruitment of autoreactive T cells that can potentially
induce bystander hepatitis, and T cells can undergo
apoptosis within the liver [31]. Thus, the presence of
autoreactive T cells may not necessarily lead to liver injury.
In summary, we have shown that mitochondrial proteins
like BCKDk can become immune targets in the mediation of
autoimmune myocarditis and/or hepatitis by generating
autoreactive T cells. It is unexpected that mitochondria which
are sub-cellular organelles can give rise to proteins capable of
generating an autoimmune response. However, other mito-
chondrial proteins have been documented to play a role in
autoimmune pathology including the E2 subunit of pyruvate
dehydrogenase, which has been shown to act as a target antigen
in themediation of primary biliary cirrhosis [32, 33] andANT1
21–40 thatwehavepreviously shown to inducemyocarditis in a
manner similar to BCKDk peptides [2]. Our studies raise
questions that how the mitochondrial proteins could be
presented specifically to autoreactive CD4 T cells to induce
disease in heart and liver. We speculate that the resident
antigen-presenting cells (APCs) uptake and display, the
immunodominant epitopes to autoreactive T cells. Still, it is
unknownwhether residentAPCs in target organs like heart and
liver display BCKDk fragments as reported for cardiac myosin
in previous studies, inwhichAPCs expressingmyosin fragment
were demonstrated in hearts fromA/Jmice [6, 12]. The heart is
a mitochondrial-rich organ, and misfolded mitochondrial
proteins if any, may be shuttled to the proteasomal
degradation. Alternatively, damaged mitochondria can
Figure 7. Disease induction by BCKDk 111-130-sensitized T cells in naive mice. LNCs prepared from animals immunized with BCKDk 111–130 were
stimulatedwith concanavalin-A for 2 days. Viable cells were administered into naivemice primedwith LPS, and naive and LPS/PT-alone groupswere used
as controls. At termination on day 14, hearts and livers were collected for H & E staining and representative sections are shown from two individual
experiments (n¼ 2/group). Top panel: normal cardiac tissues in naive and LPS/PT groups and multiple inflammatory foci in the myocardium from the
BCKDk 111–130 group are depicted. Bottom panel: naive mice had isolated foci in their livers; LPS/PT group showed no detectable lesions, whereas
prominent foci in the periportal (centroacinar) areas were detected in animals infused with BCKDk 111–130 (circles, 10 magnifications, scale bars:
80mm; horizontal arrows, 40 magnifications, scale bars: 20mm). Original magnification 400 (Scale bar: 20mm).
B. Krishnan et al. Autoimmunity induced by branched chain a-ketoacid dehydrogenase kinase
© 2017 The Authors. Immunity, Inflammation and Disease Published by John Wiley & Sons Ltd. 429
undergo degradation and they can be removed from
cardiomyocytes by a process called, mitophagy [34]. It is
possible that either of these two mechanisms can result in
immunogenic mitochondrial protein epitopes being released
from the cardiomyocytes to be taken up by resident APCs.
Additionally, in response to stressful microenvironment, cells
undergoing apoptosismay also be engulfed byAPCs as a part of
a clean-up process. Our data provide experimental support for
an observation made in humans that the antibody reactivity to
BCKD complex proteins in DCMpatients can possibly involve
the generation of BCKDk-reactive T cells, since T cell help
through cytokines is critical for antibody production.
Additionally, we noted that humans can express four isoforms
of BCKDk as opposed to mice, where no isoforms were
reported. The gene structure and amino acid sequence of
BCKDk are highly conserved between mice and humans with
94.5% identity. Comparison of sequences of BCKDk peptides
between humans andmice revealed only a single amino acid to
bedifferentwith respect toBCKDk71–90 andBCKDk141–160,
whereas the sequence of BCKDk 111–130 was fully identical in
both the species. Whether BCKDk 111–130 can also act as an
immunodominant T cell epitope in humans is currently
unknown. Proving this to be true may permit evaluation of
BCKDk-reactive T cell responses in patients with DCM in
clinical settings since BCKD-reactive immune complexes have
been demonstrated in DCM patients [3, 12, 13]. It may be
possible that cardiac damage resulting from infectious or
noninfectious causes can lead to the release of cytoplasmic
proteins like BCKDk to the extracellular milieu. Such antigens
can potentially trigger autoimmune responses and contribute
to cardiac pathology.
Materials and Methods
Ethics statement
A/J mice (6- to 8-week-old, female, H-2a) obtained from
the Jackson Laboratory (Bar Harbor, ME) and approval
for animal studies was granted by the Institutional
Animal Care and Use Committee (IACUC), University of
Nebraska-Lincoln, Lincoln, NE; IACUC protocol #: 1398.
At termination, animals were euthanized using a carbon
dioxide chamber according to the Panel on Euthanasia,
the American Veterinary Medical Association.
Peptide synthesis
A total of 37 acetylated peptides containing acetyl group at the
N-terminal end (20-mers with an overlap of 10 amino acids)
representing 380 residues of mouse BCKDk excluding the
mitochondrial signaling sequence of 32 amino acids, RNase
43–56 and biotinylated hen egg lysozyme 46–61 [20] were
used in this study were synthesized on 9-fluoreny
lmethyloxycarbonyl chemistry. All peptides were high-
performance liquid chromatography-purified (>90%), and
their identity was confirmed by mass spectroscopy
(Neopeptide, Cambridge, MA). The peptides were dissolved
in ultra-pure water, aliquoted, and stored at 208C.
Immunization procedures
Peptide emulsions were prepared in CFA containing
Mycobacterium tuberculosis H37RA extract (5mg/ml, Difco
Laboratories, Detroit, MI). Mice were immunized with these
emulsions subcutaneously on days 0 and 7. Animals also
received PT (List Biological Laboratories, Campbell, CA;
100 ng/mouse) intraperitoneally (i.p.) on days 0 and 2 after the
first immunization [21]. In pooled settings, four to five
peptides of 50mg each were mixed together, whereas mice
immunized with individual peptides received 100mg in each
injection. For MHC class II dextramer staining and cytokine
analysis for BCKDk 111–130, animals received only one dose of
peptide emulsions. Mice that received CFA/PT alone served as
controls. These animals were administered with CFA emulsion
(day 0 and 7), and PT (day 0 and 2). As an additional control
group, animals were immunized with RNase 43–56 as an
irrelevant control antigen in CFA on day 0 and 7, and PT was
administered on day 0 and 2 after the first immunization i.p.
T cell proliferation assay
LNCs obtained from animals on day 21 postimmunization
were used to assess their proliferative responses based on
tritiated-thymidine-incorporation assay. The proliferative
responses were measured as counts per minute (cpm)
[21, 22]. For easy depiction, where indicated, T cell responses
are shown as fold changes derived by dividing the cpm values
of cultures stimulated with peptides by the cpm values of
unstimulated cultures (medium controls) [2].
H & E staining
Tissues (heart, liver, lung, kidney, skeletal muscle and brain)
were collected at termination on day 21, fixed in 10%
phosphate-buffered formalin and processed for the produc-
tion of 5mm thick H & E serial sections, obtained 50mm
apart from each other. All sections were examined by a
board-certified pathologist blinded to treatment. The total
number of inflammatory cell foci was determined as
reported previously [21, 30, 35]. For evaluation of
inflammatory foci in the livers, stained sections were
scanned with the aid of Aperio digital pathology slide
scanners (Leica Biosystems, Wetzlar, Germany). After
counting the foci in the scanned images, the number of
foci was normalized to a 20mm2 area.
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Immunohistochemistry (IHC)
Hearts and livers were collected on day 21 from animals
immunized with BCKDk 111–130 and control groups (naive,
CFA/PT, and RNase 43–56) and the tissues were examined
for the presence of T cells, macrophages and granulocytes
(neutrophils). To detect T cells, sections were stained with
rabbit anti-mouse CD3 (Abcam, Cambridge, MA); for
macrophages, rabbit anti-mouse CD11b (Abcam); for
granulocytes, rat anti-mouse Ly6G (Abcam) were used.
Briefly, paraffin-embedded heart sections were deparaffi-
nized and rehydrated, and endogenous peroxidase activity
was blocked with 3% hydrogen peroxide for 30min. To
retrieve antigens, sections were treated with 10mM sodium
citrate buffer (pH 6.0) in a water bath at 988C for 15min.
After blocking for 30min with 5% non-fat dry milk, sections
were incubated with primary antibodies at 48C overnight.
Sections were incubated with goat anti-rabbit IgG or anti-rat
IgG, conjugated with HRP (Vector Laboratories, Burlin-
game, CA; and Abcam) as a secondary antibody, for 2 h at
room temperature (RT) [2]. After incubating with diami-
nobenzidine as a substrate, sections were fixed and
counterstained with hematoxylin and examined as described
above. For quantitative evaluation of CD3þ, CD11bþ, and
Ly6Gþ cells in the liver, random areas (5 to 13mm2) from
representative sections were blindly selected for each animal,
and nuclear staining was confirmed using nuclear V9
software (Aperio Technologies, Vista, CA). Cells positive for
each marker were then counted and normalized to a 1mm2
area using Aperio ImageScope Analysis Software (Leica
Biosystems, MN).
Echocardiography and image analysis
Transthoracic echocardiography was performed in anesthe-
tized (2% isoflurane, intranasal) mice on day 20 following
immunization with BCKDk 111–130. A research sonogra-
pher, blinded to the study groups, performed the measure-
ments and data analysis. Closed-chest imaging was
performed in the short-axis view at the mid-LV level,
verified by the presence of prominent papillary muscles,
using a commercially available echocardiography system
(Vivid 7, General Electric, Wauwatosa, WI) with an 11-MHz
M12-L linear array transducer. Image depth was 1.5 cm, with
acquisition of 293.6 frames/sec, second harmonic imaging
and electrocardiographic gating. From the raw 2D image of
the mid-LV, anatomical M-mode through the anteroseptal
and inferolateral segments was used to measure the width of
the intraventricular septum at diastole and the internal
diameter of the LV at diastole and systole. End-diastolic and
end-systolic volumes were calculated using the Tiechholz
formula: LV Volume¼ [7/ (2.4þ LVID)]  LVID3. A cardiac
cycle was defined from the peak of one R wave to the peak of
the following R wave. Three consecutive heart beats were
measured and the average was used for analysis.
MHC class II (IAk)-binding assay
To determine the affinities of peptides binding to IAk, soluble
IAkmolecules expressed in the baculovirus/sf9 cells were used
in the dissociation-enhanced lanthanide fluoroimmunoassay
(DELFIA) assay as we have described previously [22].
MHC class II (IAk) dextramer staining
We created two dextramers (BCKDk 111–130, specific; and
RNase 43–56, control) to determine the antigen specificity
of T cells sensitized with BCKDk 111–130 and dextramer
staining was performed as we have described previ-
ously [22]. For staining T cells generated from livers,
animals immunized with BCKDk 111–130 twice as
described above were euthanized on day 25 postimmuni-
zation, and livers collected after perfusions were homoge-
nized and digested with type IV collagenase (400U/ml;
Worthington, Lakewood, NJ). MNCs were then harvested
using 40%/75% percoll gradient centrifugation proce-
dure [22]. After stimulating with BCKDk 111–130 for
2 days, cells were rested in IL-2 medium and stained with
dextramers on day 8 poststimulation.
Cytokine bead array analysis
Groups of A/J mice were immunized with BCKDk 111–130,
and after 10 days animals were euthanized to prepare LNCs.
Similarly LNCs were obtained on day 21 postimmunization
from BCKDk 71–90 and BCKDk 141–160 immunized
animals. Cells were stimulated with or without immunizing
peptide or RNase 43–56 as control (50mg/ml). Culture
supernatants were collected on day 3 poststimulation and
analyzed by cytokine bead array analysis as recommended by
the manufacturer (BD Biosciences, Santiago, CA) [2, 35].
Induction of EAM by adoptive transfer of antigen-
sensitized T cells
Groups of mice were immunized with BCKDk 111–130 in
CFA on days 0 and 7, and after 14 days, LNCs from these
animals (2.5 106 cells/ml) were stimulated with conca-
navalin-A (2.5mg/ml; Sigma–Aldrich, St. Louis, MO) for
2 days. Viable cells were administered (50–60 106 cells/
animal) into naive mice primed with LPS (25mg/mouse;
i.p. on day 4 and day 0) [2, 23, 24]. Animals also received
PT (100 ng/mouse) i.p. on day 0 and day 2 posttransfer.
Mice that received saline or LPS/PT alone served as
controls. At termination on day 14, tissues were collected
for histology.
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Statistics
Student’s t-test was used to determine differences between
groups for inflammatory foci, number of CD3þ and
CD11bþ cells, T cell responses, echocardiography parame-
ters, and cytokines. In determining T cell responses for some
peptides with varied background levels, cpm values were
scaled within the replicates and doses, using a constant
multiplier determined by the average cpm values [2, 30].
p 0.05 was considered significant.
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Figure S1. Evaluation of cardiac abnormalities in A/J mice
immunized with BCKDk 111-130. Groups of mice were
immunized with or without BCKDk 111-130; after 20 days,
animals were euthanized, hearts were weighed, and the
heart weight (wt) to body wt ratios were then determined.
Mean SEM values representing heart and body wts and
heart wt/body wt ratios for a group of mice are shown
(n¼ 3/group). The p values were determined using
Student’s t-test (p< 0.05 and p< 0.001)
Figure S2. BCKDk peptides that induce T cell responses, but
not myocarditis in immunized animals. Groups of A/J mice
were immunized with the indicated peptides in CFA, and
after three weeks, animals were euthanized to prepare LNCs
from the draining lymph nodes. Cells were stimulated with
the immunizing peptides or RNase 43-56 (control) for two
days, and after pulsing with tritiated-thymidine for 16 h,
proliferative responses were measured as cpm. Mean SEM
values obtained from two individual experiments, each
representing 2–3 mice, are shown. The p values were
determined using Student’s t-test (p< 0.05 and p< 0.001
between indicated doses).
Figure S3. Proliferative responses of lymphocytes from naive
animals to BCKDk peptides. Lymphocytes containing a
mixture of LNCs and splenocytes obtained from naive A/J
mice were stimulated with the indicated peptides or RNase
43-56 (control) for 2 days, and after pulsing with tritiated-
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thymidine for 16 h, proliferative responses were measured as
cpm. Mean SEM values obtained from five mice are
shown.
Figure S4.Cytokine responses induced by BCKDk 71-90 and
BCKDk 141-160. LNCs were prepared from animals that
received CFA/peptide emulsions twice, and the cells were
stimulated with or without immunizing peptides or RNase
43-56 (control). Supernatants 2 collected on day 3 post-
stimulation were analyzed using cytokine-capture beads and
detection antibodies based on cytometric bead array
analysis. Left panel A): BCKDk 71-90; right panel B):
BCKDk 141-160. Mean  SEM values obtained from three
to four individual experiments are shown. The p values were
determined using Student’s t-test (p< 0.05, p< 0.005 and
p< 0.0005). ND; not detectable.
Table S1. List of overlapping peptides of BCKDk used to
determine their immunogenicity.
Table S2. T cell responses induced by peptides of BCKDk.
Table S3. Echocardiographic assessment of cardiac
abnormalities in mice immunized with BCKDk 111-130.
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